NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Thrombocytopenia due to chronic liver disease
Date of first enrollment	28/09/2015
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : S-888711 INN of investigational material : Lusutrombopag Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Safety, pharmacokinetic, efficacy
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	Main inclusion criteria Thrombocytopenic patients with chronic liver disease undergoing invasive procedures
Exclude criteria	Main exclusion criteria Patients who received blood transfusions (except for red blood cell products and albumin preparations) within 14 days prior to enrollment